Key details
Sponsor
Oculox Technologies SA
Collaborators
Latis S.r.l.
Enrollment target
~30 participants
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
50 Years and older
Last updated November 2024